Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Inspire Medical Systems Inc

2DR
Current price
162.75 EUR 0 EUR (0.00%)
Last closed 172.93 USD
ISIN US4577301090
Sector Healthcare
Industry Medical Devices
Exchange Frankfurt Exchange
Capitalization 5 892 091 904 USD
Yield for 12 month +23.18 %
1Y
3Y
5Y
10Y
15Y
2DR
21.11.2021 - 28.11.2021

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Address: 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

239.56 USD

P/E ratio

178.7455

Dividend Yield

Current Year

+624 799 000 USD

Last Year

+407 856 000 USD

Current Quarter

+203 191 000 USD

Last Quarter

+195 885 000 USD

Current Year

+528 223 000 USD

Last Year

+341 741 000 USD

Current Quarter

+170 793 000 USD

Last Quarter

+166 042 000 USD

Key Figures 2DR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 18 385 000 USD
Operating Margin TTM 7.05 %
PE Ratio 178.7455
Return On Assets TTM 1.18 %
PEG Ratio
Return On Equity TTM 5.33 %
Wall Street Target Price 239.56 USD
Revenue TTM 755 593 984 USD
Book Value 23.25 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 32.5 %
Dividend Yield
Gross Profit TTM 341 741 000 USD
Earnings per share 1.1 USD
Diluted Eps TTM 1.1 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 368.2 %
Profit Margin 4.37 %

Dividend Analytics 2DR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 2DR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 2DR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 178.7455
Forward PE 106.383
Enterprise Value Revenue 7.2876
Price Sales TTM 7.798
Enterprise Value EBITDA 142.1015
Price Book MRQ 8.4588

Financials 2DR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2DR

For 52 weeks

123 USD 257.4 USD
50 Day MA 202.63 USD
Shares Short Prior Month 1 209 887
200 Day MA 187.94 USD
Short Ratio 2.69
Shares Short 1 911 891
Short Percent 7.32 %